{"paper_id":"d535524e-35c5-4a26-8091-485ea41b9bfb","body_text":"Abstract\nSeveral studies have documented that the perimenopausal transition in terms of menstrual period intervals and duration of bleeding is similar to that which is experienced at the onset of menarche in the adolescent. That is, the interval between menstrual periods begins to lengthen and the duration of bleeding remains unchanged. Current evidence suggests that, along with the lengthening of the interval between menstrual periods, the amount of flow with each menstrual period also changes (1–3). The amount of menstrual bleeding both increases and decreases in perimenopausal women. The percentage of perimenopausal women reporting a change in menstrual flow was 51% (n = 194) of 380 women (3). An increase in the amount of menstrual flow has been positively correlated with the irregular menses that occur in perimenopausal women (2).\nPreview\nUnable to display preview. Download preview PDF.\nSimilar content being viewed by others\nReferences\nMcKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103–15.\nMetcalf MG, Donald RA, Livesey JH. Classification of menstrual cycles in pre-and perimenopausal women. J Endocrinol 1981;91:1–10.\nBurger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopause transition: a cross-sectional study of a population-based sample. J Clin Endocrinol 1995;80:3537–45.\nVan Eijkeren MA, Christiaens GCML, Sikma JJ, Haspels AA. Menorrhagia: a review. Obstet Gynecol Surv 1989;44:421–9.\nCohen BJB, Gibor Y. Anemia and menstrual blood loss. Obstet Gynecol Surv 1980;35:597–618.\nFraser IS, Baird DT. Blood production and ovarian secretion rates of estradiol-1703B2 and estrone in women with dysfunctional uterine bleeding. J Clin Endocrinol Metab 1974;39:564–70.\nShaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol 1994;101:15–18.\nSmith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981;88:434–42.\nGleeson N, Devitt M, Sheppard BL, Bonnar J. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol 1993;100:768–71.\nSantoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996; 81:1495–501.\nVan Look PFA, Lothian H, Hunter WM, Michie EA, Baird DT. Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin Endocrinol 1977;7:13–31.\nMetcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol 1981;14:245–55.\nCritchley HOD, Abberton KM, Taylor NH, Healy DL. Endometrial sex steroid receptor expression in women with menorrhagia. Br J Obstet Gynaecol 1994; 101:428–34.\nCarlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med 1993;328:856–60.\nLalonde A. Evaluation of surgical options in menorrhagia. Br J Obstet Gynaecol 1994;101:8–14.\nDonnez J, Nisolle M, Clerck F, Casanas-Roux F, Saussoy P, Gillerot S. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment. Br J Obstet Gynaecol 1994;101:2–9.\nDerman SG, Rehnstrom J, Neuwirth RS. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstet Gynecol 1991;77:591–6.\nNilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1971; 110:713–20.\nFraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust NZ J Obstet Gynecol 1991;31:66–70.\nPreston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Gynaecology 1993;102:401–8.\nCameron IT, Haining R, Lumsden M-A, Thomas VR, Smith SK. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol 1990;76:85–8.\nFraser IS. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens. Aust NZ J Obstet Gynecol 1990;30:353–6.\nHigham JM, Shaw RW. A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am J Obstet Gynecol 1993;169:1134–9.\nChimbira TH, Anderson ABM, Naish C, Cope E, Turnbull AC. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol 1980;87:1152–8.\nTang GWK, Lo SST. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Contraception 1995;51:231–5.\nAndersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690–4.\nMilsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991; 164:879–83.\nBergquist A, Rybo G. Treatment of menorrhagia with intrauterine release of progesterone. Br J Obstet Gynaecol 1983;90:255–8.\nHahn L, Petruson B. The influence of acetylsalicylic acid and paracetomol on menstrual blood loss in women with and without an intrauterine contraceptive device. Am J Obstet Gynecol 1979;135:393–6.\nChamberlain G, Freeman R, Price F, Kennedy A, Green D, Eve L. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991;98:707–11.\nvan Eijkeren MA, Christiaen GCML, Geuze HJ, Haspels AA, Sixma JJ. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. Am J Obstet Gynecol 1992;166:1419–28.\nHall P, Maclachlan N, Thorn N, Nudo MWE, Taylor CG, Garrioch DB. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. Br J Obstet Gynaecol 1987;94:554–8.\nCameron IT, Leask R, Kelly RW, Baird DT. The effects of danazol, mefenamic acid, norethisterone, and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandin 1987;34:99–110.\nMäkäräinen L, Ylikorkala O. Primary and myoma associated menorrhagia: role of prostaglandin and effects of ibuprofen. Br J Obstet Gynaecol 1986:93:974–8.\nVercellini P, Crosignani PG. Goserelin (Zoladex) and the anaemic patient. Br J Obstet Gynaecol 1994;1001:33–7.\nPetrucco OM, Fraser IS. The potential for the use of GnRH agonists for treatment of dysfunctional uterine bleeding. Br J Obstet Gynaecol 1992; 99:34–6.\nThomas EJ, Okuda KJ, Thomas NM. The combination of a depo-gonado-trophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991;98:1155–9.\nCarlson KJ, Miller BA, Fowler FJ. The Maine women’s health study: II. Outcome of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566–72.\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 1997 Springer-Verlag New York, Inc.\nAbout this chapter\nCite this chapter\nArcher, D.F. (1997). Medical Management of Menorrhagia in Pre- and Perimenopausal Women. In: Lobo, R.A. (eds) Perimenopause. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2288-0_21\nDownload citation\nDOI: https://doi.org/10.1007/978-1-4612-2288-0_21\nPublisher Name: Springer, New York, NY\nPrint ISBN: 978-1-4612-7488-9\nOnline ISBN: 978-1-4612-2288-0\neBook Packages: Springer Book Archive\nKeywords\nThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.","source_license":"CC0","license_restricted":false}